Influence of Orally Administered Probiotic Lactobacillus Strains on Vaginal Microbiota in Women with Breast Cancer during Chemotherapy: A Randomized Placebo-Controlled Double-Blinded Pilot Study.
- 2022-03-11
- Breast care (Basel, Switzerland) 12(5)
- Julian Marschalek
- Alex Farr
- Marie-Louise Marschalek
- Konrad J Domig
- Wolfgang Kneifel
- Christian F Singer
- Herbert Kiss
- Ljubomir Petricevic
- PubMed: 29234255
- DOI: 10.1159/000478994
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Sample size
- n = 22
- Population
- Postmenopausal breast cancer patients receiving chemotherapy, with vaginal atrophy and an intermediate vaginal microbiota (Nugent score 4-6) (22 patients, 11 vs. 11)
- Methods
- Patients were randomized to receive probiotic capsules of 4 Lactobacillus species or placebo twice daily for 2 weeks; consecutive vaginal swabs were taken at baseline, 1 day after the last capsule, and after 1 week
Background
Due to chemotherapy and estrogen deprivation therapy, genitourinary syndrome of menopause is a common condition in breast cancer patients. We aimed to determine the effect of an orally administered Lactobacillus preparation on the vaginal microbiota in breast cancer patients.Methods
Postmenopausal breast cancer patients receiving chemotherapy, with vaginal atrophy and an intermediate vaginal microbiota (Nugent score 4-6), were either randomized to the intervention group receiving probiotic capsules of 4 Lactobacillus species or to the control group receiving placebo twice daily for 2 weeks. Consecutive vaginal swabs were taken at baseline, 1 day after administration of the last capsule (follow-up 1), and after 1 week (follow-up 2) in 22 patients (11 vs. 11).Results
We observed a positive influence on the vaginal microbiota in 7/11 (63%) women in the intervention group, and 4/11 (36%) women in the control group. There was a shift in Nugent score towards normal microbiota levels in the intervention group (-1.3 at follow-up 1, -0.45 at follow-up 2) and a significant deterioration of the Nugent score in the control group (+0.4 at follow-up 1, +2.5 at follow-up 2).Conclusion
The orally administered Lactobacillus preparation has the potential to improve the vaginal microbiota in women undergoing chemotherapy for breast cancer.Research Insights
We observed a positive influence on the vaginal microbiota in 7/11 (63%) women in the intervention group, and 4/11 (36%) women in the control group. There was a shift in Nugent score towards normal microbiota levels in the intervention group
- Effect
- Beneficial
- Effect size
- Small